A large subset of DMD patients also have neurodevelopmental problems, of which the cellular basis remains poorly understood, a problem that is compounded by the limited understanding of dystrophin function in the central nervous system (CNS). The gene discussed is DMD; the disease is Duchenne muscular dystrophy.